1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsHospital-Based Violence Intervention Program (HVIP) Expansion-Learning Community is sponsored by Oregon Health Authority. This grant opportunity supports the development of hospital-based violence intervention programs.
Get alerted about grants like this
Save a search for “Oregon Health Authority” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Oregon Health Authority : Community Violence Prevention : Injury and Violence Prevention : State of Oregon Translate this site into other Languages tag, as divs are not allowed in 's --> Community Violence Prevention Oregon House Bill 4045 defined community violence as an intentional act of interpersonal violence committed in public by someone who is not the victim’s family member or intimate partner.
The Oregon Health Authority’s Injury & Violence Prevention and Medicaid Programs are supporting development of sustainable programs to help communities break the cycle of community violence. ***NEW: Funding Opportunity*** With funding allocated by 2022 Oregon House Bill 4045, the Oregon Health Authority will release a new grant opportunity to support development of hospital-based violence intervention programs .
Hospitals and community-based, non-profit organizations in Oregon that serve people outside Multnomah County can request funding to participate in the Hospital-Based Violence Intervention Program (HVIP) Expansion-Learning Community. Once released, the grant application will be posted in OregonBuys, the state's web-based eProcurement system: https://oregonbuys. gov/bso/ .
The website will be updated when the grant opportunity becomes available. In advance of the grant release, please contact Molly Taylor at molly. taylor@oha.
oregon. gov with any funding-related questions. For any assistance with OregonBuys, please follow: https://www.
oregon. gov/das/ORBuys/Pages/supplierresources. aspx https://www.
oregon. gov/das/ORBuys/Documents/OregonBuys%20Vendor%20Formal%20Solicitation%20Response. pdf OregonBuys Supplier Support: support.
oregonbuys@das. oregon.
gov Violence Prevention Resources Hospital-based violence intervention programs (HVIPs) Bullet Points Project: HVIPs Health Alliance for Violence Intervention (HVIP) Portland Opportunities Industrialization Center - Healing Hurt People Program Newark Community Street Team HVIP Medicaid Billing for HVIP services Center for Medicaid and Medicare Services (CMS) - What is a State Plan Amendment Oregon State Plan Amendment (SPA) Community Violence Prevention Services Oregon Administrative Rules: Chapter 410 Division 152: Community Violence Prevention Services HB 4045 Implementation Update HB 4045 Technical Advisory Group Report How to recognize an official Oregon website Only share sensitive information on official, secure websites.
Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how
Based on current listing details, eligibility includes: Hospitals and community-based, non-profit organizations in Oregon that serve people outside Multnomah County. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.